Electra Therapeutics, Inc.

US$7.80As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ETRAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$489.6M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.83
25.99%
(44.83%)
Hold 3|1|9|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.11
0.11
0.10
0.11
11.10%
11.80%
7.74%
8.84%
Revenue$M
40.07
42.30
41.11
41.31
3.50%
11.22%
5.48%
2.70%
Peers (US$489.6M)
Cap (US$)
PE
483.0M
—
486.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.691
0.346
0.285
EBIT/Intx
0.762
0.188
0.184
Own earn%
(64.50)
(1.83)
(25.34)
Sh yield%
15.37
37.02
33.42
Owners
Insiders/Inst%
12.80
54.53
Short interest%
5.71
SBC / revenue%
4.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
18–26
$1 testx
0.1
Incr. ROIC%
5